Clinical Evidence on GLP-1 and Oral Contraceptive Interaction Direct clinical trials specifically measuring birth control efficacy during GLP-1 therapy remain sparse
Reduced Cognitive Decline : General cognitive decline, such as memory loss or confusion, was also less common among Ozempic users 1
From a baseline average HbA1c of 8.3%, it was found that after 52 weeks, orforglipron was able to reduce this value by an average of 1.711.91%
That is one of the reasons, as the NICE guideline says, that we need to adjust treatment to the patients symptoms, not do a blood test or prescribe a one-size-fits-all dose
Here's the complete scorecard, what it means, what it doesn't, and what to do next